• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SAPHEON INC VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SAPHEON INC VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT Back to Search Results
Catalog Number SP-101
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Numbness (2415)
Event Date 05/25/2017
Event Type  Injury  
Event Description
A venaseal device was used for the vein closure procedure of the right great saphenous vein.It was reported that the procedure was completed normally per ifu.The vein closed.Patient experienced unilateral numbness 24 hours post venaseal closure system treatment.The patient was diagnosed as questionable stroke by neurologists.Symptoms improved quickly, but according to the last report, some unilateral numbness remains.It was reported that the brain mri was normal and the cardiac echogram was normal with no evidence of pfo/septal defect.Physician reported that since there has been significant improvement, the diagnosis could perhaps be prind (prolonged reversible ischemic neurological deficit), rather than cva (cerebrovascular accident).It is reported that the physician is unsure, doubtful if the event is related to the venaseal device or procedure.
 
Manufacturer Narrative
Additional information: it is reported that the patient developed atypical neurological symptoms starting over 24 hours afterwards with fluctuating numbness and weakness of their right arm despite two normal mris of the brain.The patient had generalised lethargy and possible palpitations which can wake them at night.It is believed an echocardiogram has excluded paradoxical thrombo-embolism.A dvt has been excluded.Patient was not treated with any foam sclerosant.The physician notes it is possible that the patient has intermittent tachyarrythmia as a source of their palpitations and possible tia.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENA SEAL CLOSURE SYSTEM
Type of Device
AGENT, OCCLUDING, VASCULAR, PERMANENT
Manufacturer (Section D)
SAPHEON INC
951 aviation pkwy ste 900
morrisville NC 27560
Manufacturer (Section G)
SAPHEON INC
951 aviation pkwy ste 900
morrisville NC 27560
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key6665473
MDR Text Key78347463
Report Number3011410703-2017-00267
Device Sequence Number1
Product Code PJQ
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
P140018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 06/26/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/23/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/31/2018
Device Catalogue NumberSP-101
Device Lot Number45417
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/26/2017
Date Device Manufactured11/09/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age45 YR
-
-